Orion Portfolio Solutions, LLC Veracyte, Inc. Transaction History

Orion Portfolio Solutions, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$18.86 - $23.55 $18,746 - $23,408	-994 Reduced 4.82%	19,629 $425,000
Q1 2024 May 09, 2024	BUY	$21.0 - $29.1 $32,571 - $45,134	1,551 Added 8.13%	20,623 $457,000
Q4 2023 Feb 09, 2024	SELL	$19.72 - $28.68 $13,764 - $20,018	-698 Reduced 3.53%	19,072 $524,000
Q3 2023 Nov 01, 2023	SELL	$22.33 - $29.92 $9,601 - $12,865	-430 Reduced 2.13%	19,770 $441,000
Q2 2023 Aug 14, 2023	SELL	$20.96 - $26.99 $11,884 - $15,303	-567 Reduced 2.73%	20,200 $514,000
Q1 2023 Aug 30, 2023	BUY	$20.58 - $27.89 $11,668 - $15,813	567 Added 2.81%	20,767 $463,000
Q1 2023 May 15, 2023	BUY	$20.58 - $27.89 $427,384 - $579,191	20,767 New	20,767 $463,000

320

80.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.